Agena Bioscience® in the News

Recent Press Releases

  • Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel More

    San Diego, CA – Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY®

  • Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking More

    San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it has obtained CE-IVD

  • Agena Bioscience Announces Release of High-Throughput, Low-Cost SARS-CoV-2 Panel More

    San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the SARS-CoV-2

  • Agena Improves PGx Testing Accuracy with Launch of VeriDose™ CYP2D6 CNV Panel More

    Quantification of Hybrid Alleles Not Detected by Common PGx TechnologiesSan Diego, CA, November 4, 2019– Agena Bioscience, a global provider of molecular

  • Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis More

    San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID

  • Agena and DaRui Biotechnology Announce China FDA Clearance of MassARRAY® Technology for Diagnostic Use in China More

    San Diego, CA and Guangzhou, China, Wednesdy, October 24, 2018 - Agena Bioscience (Agena) and DaRui Biotechnolog (DaRui) announced today that the MassARRAY®